Hemodynamic effect of propofol in enalapril-treated hypertensive patients during induction of general anesthesia

Pharmacological Reports

Volumn 57, Issue 5, 2005, Pages 675-678

  Malinowska Zaprzałka, Małgorzata ^a   Wojewódzka, Marzena ^a   Dryl, Dorota ^a   Grabowska, Stanisława Z ^a   Chabielska, Ewa ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Anesthesia induction; Angiotensin converting enzyme inhibitor; Hemodynamics; Propofol

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ETOMIDATE; FENTANYL; INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM; NITRIC OXIDE; OXYGEN; PROPOFOL; SUXAMETHONIUM;

ANESTHESIA INDUCTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENERAL ANESTHESIA; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; STATISTICAL ANALYSIS; VASCULAR ENDOTHELIUM;

EID: 33646195081     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Andres J, Podolec P: The significance of the pharmacological blockade of the cardiovascular system in anaesthesiology. Nowa Medycyna, 1997, 4, 17-19.
2. Basu S, Mutschler DK, Larsson A, Kiiski R, Nordgren A, Eriksson MB: Propofol counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation, 2001, 50, 341-348.
3. Kelicen P, Ismailoglu UB, Erdemli O, Sahin-Erdemli I: The effect of propofol and thiopentone on impairment by reactive oxygen species of endothelium-dependent relaxation in rat aortic rings. Eur J Anaesthesiol, 1997, 14, 310-315.
4. Kondo U, Kim SO, Murray PA: Propofol selectively attenuates endothelium-dependent pulmonary vasodilation in chronically instrumented dogs. Anaesthesiology, 2000, 93, 437-446.
5. Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR: Long-term angiotens-inconverting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology, 1996, 84, 789-800.
6. Linz W, Scholkens BA, Han YF: Beneficial effects of the angiotensin converting enzyme inhibitor, ramipril, in ischemic rat hearts. J. Cardiovasc Pharmacol, 1986, 8, Suppl 10, S91-99.
7. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev, 1995, 47, 25-49.
8. Littler C, McConachie I, Healy TEJ: Interaction between enalapril and propofol. Anesth Intensive Care, 1989, 17, 514-515.
9. Malinowska-Zaprzałka M: Influence of propofol, thiopental and etomidate on serotonin turnover in circulatory system in man. Med Sci Monit, 1997, 6, 840-848.
10. Mancini GB, Henry GC, Macaya C, O'Neill, BJ, Pucillo AL, Carere RG, Wargovich TJ et al.: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation, 1996, 94, 258-265.
11. Mangano DT: Perioperative cardiac morbidity. Anesthesiology, 1990, 72, 153-184.
12. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H, Kinoshita M: Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol, 2001, 37, 1565-1570.
13. Nathan N, Vial G, Benrhaiem M, Peyclit A, Feiss P: Induction with propofol target-concentration infusion vs. 8% sevoflurane inhalation and alfentanil in hypertensive patients. Anaesthesia, 2001, 56, 248-271.
14. Riznyk L, Fijałkowska M, Przesmycki K: Effects of thiopental and propofol on heart rate variability during fentanyl-based induction of general anesthesia. Pharmacol Rep, 2005, 57, 128-134.
15. Rousseau MF, Gurne O, Van Eyll C: Effects of benazeprilat on left ventricular systolic and diastolic function and neurohumoral status in patients with ischemic heart disease. Circulation, 1990, 81, 2 Suppl, III123-129.
16. Ryckwater F, Colson P: Hemodynamic changes of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg, 1997, 84, 945-949.
17. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L: Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Anaesthesia, 1988, 61, 675-679.
18. Wallner T, Preis C, Mayer N: Cardiac medication in the perioperative period. Acta Anaesthesiol Scand Suppl, 1997, 111, 22-28.